InsiderClue
Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686
$41.10 +4.71% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $41.10 +303.34% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue21.90Operating income2.15Net income0.33EPS, diluted0.07Fiscal year 2017Revenue21.85 −0.2%Operating income−17.48Net income−16.27 −5,043.8%EPS, diluted−16.26Fiscal year 2018Revenue18.27 −16.4%Operating income−1.64Net income−2.15EPS, diluted−2.35Fiscal year 2019Revenue16.89 −7.6%Operating income−0.44Net income−1.00EPS, diluted−0.91Fiscal year 2020Revenue16.66 −1.4%Operating income−3.57Net income−3.99EPS, diluted−3.64Fiscal year 2021Revenue15.88 −4.7%Operating income1.72Net income0.42EPS, diluted0.38Fiscal year 2022Revenue14.93 −6.0%Operating income−2.20Net income−2.45 −686.6%EPS, diluted−2.20Fiscal year 2023Revenue15.85 +6.2%Operating income0.43Net income−0.56EPS, diluted−0.50Fiscal year 2024Revenue16.54 +4.4%Operating income−0.30Net income−1.64EPS, diluted−1.45Fiscal year 2025Revenue17.26 +4.3%Operating income2.16Net income1.41EPS, diluted1.21
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 21.90 21.85 18.27 16.89 16.66 15.88 14.93 15.85 16.54 17.26
Growth −0.2% −16.4% −7.6% −1.4% −4.7% −6.0% +6.2% +4.4% +4.3%
Operating income 2.15 −17.48 −1.64 −0.44 −3.57 1.72 −2.20 0.43 −0.30 2.16
Net income 0.33 −16.27 −2.15 −1.00 −3.99 0.42 −2.45 −0.56 −1.64 1.41
Growth −5,043.8% −686.6%
EPS, diluted 0.07 −16.26 −2.35 −0.91 −3.64 0.38 −2.20 −0.50 −1.45 1.21

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin53.2%Operating margin9.8%Net margin1.5%Free cash flow margin13.6%Fiscal year 2017Gross margin48.6%Operating margin−80.0%Net margin−74.4%Free cash flow margin6.2%Fiscal year 2018Gross margin45.4%Operating margin−9.0%Net margin−11.8%Free cash flow margin9.8%Fiscal year 2019Gross margin44.6%Operating margin−2.6%Net margin−5.9%Free cash flow margin1.3%Fiscal year 2020Gross margin46.4%Operating margin−21.4%Net margin−24.0%Free cash flow margin3.8%Fiscal year 2021Gross margin47.8%Operating margin10.8%Net margin2.6%Free cash flow margin1.5%Fiscal year 2022Gross margin46.7%Operating margin−14.7%Net margin−16.4%Free cash flow margin7.0%Fiscal year 2023Gross margin48.2%Operating margin2.7%Net margin−3.5%Free cash flow margin5.3%Fiscal year 2024Gross margin48.7%Operating margin−1.8%Net margin−9.9%Free cash flow margin4.5%Fiscal year 2025Gross margin51.8%Operating margin12.5%Net margin8.2%Free cash flow margin6.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 53.2% 48.6% 45.4% 44.6% 46.4% 47.8% 46.7% 48.2% 48.7% 51.8%
Operating margin 9.8% −80.0% −9.0% −2.6% −21.4% 10.8% −14.7% 2.7% −1.8% 12.5%
Net margin 1.5% −74.4% −11.8% −5.9% −24.0% 2.6% −16.4% −3.5% −9.9% 8.2%
Free cash flow margin 13.6% 6.2% 9.8% 1.3% 3.8% 1.5% 7.0% 5.3% 4.5% 6.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow3.89Capital expenditure−0.90Free cash flow2.99Dividends paid−1.30Fiscal year 2017Operating cash flow2.23Capital expenditure−0.87Free cash flow1.35 −54.8%Dividends paid−0.90Fiscal year 2018Operating cash flow2.45Capital expenditure−0.65Free cash flow1.80 +32.9%Dividends paid−0.01Fiscal year 2019Operating cash flow0.75Capital expenditure−0.53Free cash flow0.22 −87.6%Fiscal year 2020Operating cash flow1.22Capital expenditure−0.58Free cash flow0.64 +186.1%Fiscal year 2021Operating cash flow0.80Capital expenditure−0.56Free cash flow0.24 −63.0%Fiscal year 2022Operating cash flow1.59Capital expenditure−0.55Free cash flow1.04 +341.5%Fiscal year 2023Operating cash flow1.37Capital expenditure−0.53Free cash flow0.84 −19.2%Fiscal year 2024Operating cash flow1.25Capital expenditure−0.50Free cash flow0.75 −11.0%Fiscal year 2025Operating cash flow1.65Capital expenditure−0.50Free cash flow1.15 +53.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 3.89 2.23 2.45 0.75 1.22 0.80 1.59 1.37 1.25 1.65
Capital expenditure −0.90 −0.87 −0.65 −0.53 −0.58 −0.56 −0.55 −0.53 −0.50 −0.50
Free cash flow 2.99 1.35 1.80 0.22 0.64 0.24 1.04 0.84 0.75 1.15
Growth −54.8% +32.9% −87.6% +186.1% −63.0% +341.5% −19.2% −11.0% +53.3%
Dividends paid −1.30 −0.90 −0.01 n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.99Total debt33.33Net cash (debt)−32.35Shareholders’ equity33.34Debt to equity1.00Fiscal year 2017Cash0.96Total debt31.71Net cash (debt)−30.75Shareholders’ equity17.36Debt to equity1.83Fiscal year 2018Cash1.78Total debt1.70Net cash (debt)0.08Shareholders’ equity14.71Debt to equity0.12Fiscal year 2019Cash1.98Total debt1.83Net cash (debt)0.14Shareholders’ equity13.97Debt to equity0.13Fiscal year 2020Cash2.18Total debt2.67Net cash (debt)−0.50Shareholders’ equity10.03Debt to equity0.27Fiscal year 2021Cash2.17Total debt1.40Net cash (debt)0.76Shareholders’ equity10.28Debt to equity0.14Fiscal year 2022Cash2.80Total debt2.09Net cash (debt)0.72Shareholders’ equity7.80Debt to equity0.27Fiscal year 2023Cash3.23Total debt1.65Net cash (debt)1.58Shareholders’ equity7.51Debt to equity0.22Fiscal year 2024Cash3.30Total debt1.76Net cash (debt)1.54Shareholders’ equity5.37Debt to equity0.33Fiscal year 2025Cash3.56Total debt1.80Net cash (debt)1.76Shareholders’ equity7.91Debt to equity0.23
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.99 0.96 1.78 1.98 2.18 2.17 2.80 3.23 3.30 3.56
Total debt 33.33 31.71 1.70 1.83 2.67 1.40 2.09 1.65 1.76 1.80
Net cash (debt) −32.35 −30.75 0.08 0.14 −0.50 0.76 0.72 1.58 1.54 1.76
Shareholders’ equity 33.34 17.36 14.71 13.97 10.03 10.28 7.80 7.51 5.37 7.91
Debt to equity 1.00 1.83 0.12 0.13 0.27 0.14 0.27 0.22 0.33 0.23

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017† 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
0.99 0.96 1.78 1.98 2.18 2.17 2.80 3.23 3.30 3.56
7.52 7.13 5.82 5.68 4.58 4.53 3.70 3.41 3.06 3.71
4.95 4.92 4.73 4.42 4.40 3.82 3.83 4.02 3.01 3.18
8.07 7.67 6.87 6.44 6.30 5.98 5.74 5.75 4.58 4.08
44.41 28.41 24.92 24.85 20.62 17.63 17.18 17.18 15.15 16.00
93.06 70.62 60.68 57.47 50.64 47.67 44.01 43.48 39.33 40.75
Growth −24.1% −14.1% −5.3% −11.9% −5.9% −7.7% −1.2% −9.6% +3.6%
Liabilities
0.81 2.88 1.70 1.83 2.67 1.40 2.09 1.65 1.76 1.80
32.52 28.83 n/a n/a n/a n/a n/a n/a n/a n/a
calc 33.33 31.71 1.70 1.83 2.67 1.40 2.09 1.65 1.76 1.80
58.06 51.87 44.89 42.41 39.58 36.42 35.41 35.35 33.61 32.83
Equity
13.61 −3.80 −5.96 −6.96 −10.95 −10.53 −12.98 −13.53 −15.17 −13.76
33.34 17.36 14.71 13.97 10.03 10.28 7.80 7.51 5.37 7.91
Growth −47.9% −15.3% −5.0% −28.2% +2.5% −24.1% −3.8% −28.4% +47.2%
Per share and net cash
calc −32.35 −30.75 0.08 0.14 −0.50 0.76 0.72 1.58 1.54 1.76
1,123 1,018 1,089 1,092 1,097 1,103 1,111 1,121 1,134 1,150
calc 29.68 17.05 13.50 12.79 9.14 9.32 7.02 6.70 4.74 6.88

† The diluted share count jumps at 2017, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.